Abstract
Introduction
Tumor necrosis factor (TNF)-α is a pleiotropic cytokine that appears to be required for resistance to several pathogens (1) . It is released by a variety of cells of hematopoietic and non-hematopoietic origin (1,2) during infection with Gramnegative (3) or Gram-positive (4, 5) bacteria, viruses (6) , parasites (7) and fungi (8) (9) (10) . The low-levels of TNF-α present in sublethal microbial infections are required for optimal antimicrobial defense to occur, as revealed by the high susceptibility to microbial infections of mice lacking functional TNF-α (11) (12) (13) (14) (15) . In contrast, high TNF-α levels, observed in the course of experimental lethal infections and associated pathology (16) or in patients with overwhelming infections (17) , initiate biochemical and physiologic reactions that result in end-organ failure and septic shock (18) . Locally secreted TNF-α may act alone or synergistically with other cytokines to regulate MHC class II cellular expression (19) , to enhance production of microbiocidal reactive nitrogen intermediates by macrophages (20) and to induce IFN-γ production by NK cells (21) . In addition, mice lacking the p55 TNF receptor (22) and/or lymphotoxin (LT)-α (23, 24) , that bind to the same receptor, have multiple abnormalities of the immune system, such as absence of lymph nodes and Peyer's patches, defective germinal center formation and differentiation of follicular dendritic cells. These findings suggest an important role for TNF in the development and physiology of the immune system. In this study, TNF/LT-α-deficient mice, generated by homologous recombination in mouse embryonic stem cells (25) , were used to assess the requirement of TNF/LT-α signaling in the development of protective immunity to Candida albicans in mice. C. albicans is an opportunistic fungal pathogen that is associated with severe infections and diseases in humans (26) . Mechanisms of both innate and acquired immunity cooperate for induction of optimal anticandidal responses (27) . Besides regulating the initial fungal burden in vivo through potent antifungal effector activities, cells of the innate immune system secrete a variety of cytokines with important immunoregulatory functions (28, 29) . Thus, induction of protective T h 1 cell responses to the fungus requires the coordinated actions of several cytokines (30) , including IL-12 which is mainly produced by neutrophils (31) (32) (33) . Depletion of neutrophils renders mice highly susceptible to disseminated infection and impairs development of T h 1 responses, which could be efficiently restored by replacement therapy with IL-12 (33) . In the course of systemic C. albicans infection, TNF-α is rapidly detected in the serum and progressively increases until death (9, (34) (35) (36) . Administration of exogenous TNF-α increases whereas inhibition of endogenous TNF-α decreases resistance to infection, thus confirming the protective role of TNF-α in infection (34, 35, 37) , as suggested by studies in highly susceptible TNF receptor p55-deficient mice (15) . Both macrophages and neutrophils secrete TNF-α upon exposure to the fungus (38, 39) or its mannan component (40) ; however, the former cells are the major sources of this cytokine in vivo (36) . The release of TNF-α by macrophages during the early phase of the inflammatory response to the fungus is believed to attract and activate neutrophils for antifungal effector functions (41) . However, TNF-α also decreases in vitro fungicidal activity against C. albicans hyphae (42) , thus suggesting that TNF-α may deliver both positive and negative signals to effector phagocytic cells. Although all the above considerations would predict TNF/LT-α-deficient mice be highly susceptible to many infectious agents, including C. albicans, no studies have been performed on the importance of TNF/LT-α signaling on the type of T h immune response elicited in mice with C. albicans infection. In the present study, we found that the high susceptibility of TNF/LT-α-deficient mice to either systemic or gastrointestinal candidiasis correlated with an impaired development of protective T h 1 responses, which was associated with defective antifungal effector and costimulatory functions of phagocytic cells.
Methods

Mice
TNF/LT-α -/-and wild-type TNF/LT-α ϩ/ϩ mice on a mixed 129SVϫC57BL/6 background (25) were bred under specific pathogen-free conditions. Mice of both sexes, 8-10 weeks old, were used. Procedures involving animals and their care were conducted in conformity with national and international laws and policies.
Yeasts, infections, in vivo analysis and treatment
The origin and characteristics of the C. albicans highly virulent CA-6 strain and the live vaccine strain PCA-2 used in this study have already been described in detail (43) (44) (45) . For infection, cells were washed twice in saline and diluted to the desired density to be injected i.v., via the lateral tail vein in a volume of 0.5 ml/mouse, or intragastrically (i.g.), via an 18G 4 cm long plastic catheter, as described (46) . The viability of the cells was Ͼ95% by Trypan blue exclusion and quantitative cultures. Quantification of yeast cells in the organs of infected mice (four to six per group) was performed by a platedilution method, using Sabouraud dextrose agar, and results (means Ϯ SEM) were expressed as c.f.u. per organ. Resistance to reinfection was assessed by injecting mice with 10 6 CA-6 cells i.v., 14 days after primary infection. For histology, tissues were excised and immediately fixed in formalin. Sections (3-4 mm) of paraffin-embedded tissues were stained with periodic acid-Schiff reagent and examined for histology, as described (43, 44, 46) . Mice succumbing to yeast challenge were routinely necropsied for histopathological confirmation of disseminated candidiasis. Recombinant murine TNF-α, purchased from Genzyme (Cambridge, MA), was given s.c. at the total dose of 3 µg, twice the day of and once the day after the infectious challenge. Control mice received vehicle alone.
Purification and culture of cells
Splenic T cells were obtained by sequential adherence of splenocytes on anti-Ig-coated plates (polyclonal goat antimouse Ig; Sigma, St Louis, MO) to remove B cells, followed by 2 h plastic adherence on plates at 37°C to remove residual contaminating macrophages. For cultures, T cells (5ϫ10 6 ) were stimulated with 10 µg of concanavalin A (Con A; Sigma) in the presence of 5ϫ10 5 splenic adherent macrophages as accessory cells (Ͼ95% pure on esterase staining), as described (44) . CD4 ϩ lymphocytes were positively selected from pools of spleen cells by means of a panning procedure using purified anti-murine CD4 mAb (GK1.5 hybridoma from ATCC, Rockville, MD), which resulted in a Ͼ95% pure population on flow cytometric analysis (43) (44) (45) . CD4 ϩ cells (5ϫ10 6 ) were cultured in the presence of 5ϫ10 5 accessory macrophages and heat-inactivated yeast cells. Intragastric lymphocytes (IGL) were isolated from the whole stomach, as described (47) . After extensive washing with sterile HBSS, the stomach was cut in small pieces and tissues were sequentially incubated for 3 times in calcium and magnesium ion-free HBSS containing dithiothreitol (DTT, 0.145 mg/ml; Sigma) and EDTA (0.37 mg/ml) at 37°C for 15 min, and digested further in RPMI 1640 containing collagenase VIII (100 U/ml; Sigma) and DNase I (0.1 mg/ml; Sigma) at 37°C. After passage through nylon wool columns to eliminate clumps and adherent cells, lymphocyte-enriched populations were isolated at the 40-100% interface of a discontinuous Percoll gradient (Pharmacia, Uppsala, Sweden). Then, 5ϫ10 5 IGL [containing cells of both CD8 (~77%) and CD4 (7 to 9%) phenotypes, with CD4 ϩ T cells expressing the αβ or γδ TCR at approximately equal number on FACS analysis, data not shown] were cultured in the presence of irradiated (2,000 rad) splenocytes and 10 µg/ml of Con A. Cultures of plasticadherent macrophages from spleen cells and purified peritoneal neutrophils, collected 18 h after i.p. inoculation of aged, endotoxin-free 10% thioglycollate solution (Difco, Detroit, MI), were done as described (32, 33) by incubating 5ϫ10 6 cells in the presence of IFN-γ (400 U/ml) and 40 ng/ml of lipopolysaccharide (LPS; Sigma). Cytokine measurement was per-formed in supernatants collected after 48 h (for lymphocytes) and 24 h (for phagocytic cells).
Feces
Cytokine contents in feces were determined by processing fecal samples, as described (46) .
Cytokine assays
The levels of IFN-γ, IL-2, IL-4 and IL-6 were determined in serum, supernatants and feces by means of cytokine-specific ELISA, using pairs of anti-cytokine mAb, as described (32, 33, (43) (44) (45) (46) 48) . The antibody pairs, listed by capture/ biotinylated detection, were as follows: IFN-γ, R4-6A2/XMG1.2; IL-2, JES6-1A12/JES6-5H4; IL-4, BVD4-1D11/BVD6-24G2; IL-6, MP5-20F3/MP5-32c11 (PharMingen, San Diego, CA). For IL-12 p70 measurement, a modified antibody-capture bioassay was used (49) . Cytokine titers were expressed as ng/ml or U/ml for IL-6 and IL-2, calculated by reference to standard curves constructed with known amounts of recombinant (r) cytokines (from PharMingen; except IL-12, Genetics Institute, Cambridge, MA).
Antibody assay
A micro-ELISA procedure was used to quantitate yeastspecific IgE or IgG2a in the sera of mice (43, 46, 48) . The assay involved coating the microtiter plate wells with Candida whole cells, addition of appropriate dilutions of test antisera and a further reaction with biotinylated rat anti-mouse IgE mAb (Sanbio, Uden, The Netherlands), and then with avidinalkaline phosphatase conjugate or phosphatase-conjugated rabbit anti-mouse IgG2a (Zymed, San Francisco, CA). After addition of the substrate solution, the OD of triplicate samples was read with an ELISA reader, using a 405 nm filter.
Candidacidal assay, phagocytosis and NO production
For the candidacidal assay, 5ϫ10 5 neutrophils or macrophages/0.1 ml/well were plated in 96-well flat-bottom microtiter plates (Costar, Cambridge, MA) and incubated with 10 5 PCA-2 cells for 1 or 4 h respectively, as described (50, 51) . Triton X-100 was then added to the wells and serial dilutions from each well were made in distilled water. Pour plates (four to six replicate samples) were made by spreading each sample on Sabouraud glucose agar. The number of c.f.u. was determined after 18 h of incubation at 37°C and the percentage of c.f.u. inhibition (mean Ϯ SE) was determined as follows: percentage of colony forming inhibition ϭ 100 -(c.f.u. experimental group/c.f.u. control cultures)ϫ100. Control cultures consisted of C. albicans cells incubated without effector cells. Measurement of phagocytic activity in vitro was performed by mixing equal volumes (0.1 ml) of effector cells (plastic adherent splenic macrophages or peritoneal neutrophils) and a suspension of unopsonized PCA-2 C. albicans cells at an effector to yeast cell ratio of 1:10. After incubation at 37°C for 4 h (macrophages) or 1 h (neutrophils), phagocytic cells were separated from non-phagocytosed C. albicans cells by centrifugation on a fetal bovine serum gradient and 0.1 ml sample of the harvested phagocytic cells was used for cytospin preparation. The phagocytic activity of effector cells was expressed according to the following formula: percentage of phagocytic activity ϭ number of cells containing one or more yeast cells/100 cells counted. For nitrite determination, a measure of NO synthesis, macrophages and neutrophils were cultured in the presence of IFN-γ and LPS for 18 h before assaying NO production in the culture supernatants, by a standard Griess reaction, as described previously (50, 51) .
Flow cytometry
Flow cytometry analysis was performed as previously described (49, 52) . Splenic adherent macrophages and macrophage-depleted splenocytes (referred to as lymphocytes) were sequentially reacted with saturating amounts of purified mAb, followed by FITC-conjugated affinity pure goat anti-rat IgG (H ϩ L) or anti-Syrian hamster IgG (H ϩ L) (Jackson Immunoresearch Laboratories, West Grove, PA). The following mAb (from PharMingen) were used: purified anti-CD80 (B7-1, rat IgG2a, mAb 1G10), anti-CD86 (B7-2, rat IgG2a, mAb GL1), anti-CD40 (hamster IgM, hybridoma HM40-3) and mAb anti-CD40L (hamster IgG, hybridoma MR1). 
RNA preparation and RT-PCR
Splenic adherent macrophages and purified CD4 ϩ T cells from pooled spleens of three to four animals were subjected to RNA extraction by the guanidium thiocyanate-phenolchloroform procedure, as described (53) . Briefly, 3 µg of total RNA was incubated with 0.5 µg of oligo(dT) (Pharmacia) for 3 min at 65°C and chilled on ice for 5 min. Each sample was then incubated for 1 h at 37°C after adding 1.5 mM deoxynucleoside triphosphates, 200 U M-MLV RT (Gibco BRL, Bethesda, MD) and RT buffer (250 mM Tris-HCl, pH 8.3, 15 mM MgCl2, 375 mM KCl and 10 mM DTT, final concentrations) in a final volume of 20 µl. cDNA was diluted to a total volume of 100 µl with TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and frozen at -20°C until use. Amplification of synthesized cDNA from each sample was carried out as described previously (54) . Briefly, 5 µl of cDNA was added to a reaction mixture containing 50 mM KCl, 10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl 2 , 0.01% gelatin, 0.2 mM deoxynucleoside triphosphates, 1 µM of each primer and 1 U AmpliTaq polymerase (Perkin-Elmer, Hayward, CA). Each 5 µl sample was overlaid with 25 µl mineral oil (Sigma) and incubated in a DNA Thermal Cycler 480 (Perkin-Elmer) for a total of 30-35 cycles for each cytokine. For HPRT, IFN-γ, IL-4 and IL-10, the primers, positive controls, cycles and temperature were as described elsewhere (43) (44) (45) 48, 49) . For IL-12 receptor β1 and β2 (IL-12Rβ1 and IL-12Rβ2), the primers were synthesized using a 391 DNA synthesizer (PCR-MATE; Applied Biosystems, Foster City, CA). The sequences of 5Ј sense primers and 3Ј antisense primers for IL-12Rβ1 and IL-12Rβ2 were as follows: IL-12β1, 5Ј-GAACCACACACACTGTACCCTG; 3Ј-TTTAGTGGGTGGCACGAGCC; IL-12β2, 5Ј-CAAGACATCGA-CTATGACAGAC; 3Ј-CAGGTTGTGCTGTCGAGTCTCG. For IL-12Rβ1 and β2, each cycle consisted of 1 min at 94°C, 1 min at 60°C and 1 min at 72°C. The primer sequences and positive controls were obtained through the courtesy of Dr Giorgio Trinchieri (Wistar Institute, Philadelphia, PA). The HPRT primers were used as a control for both RT and the PCR reaction itself, and also for comparing the amount of products from samples obtained with the same primer. The PCR fragments were analyzed by 1.5% agarose gel electrophoresis and visualized by ethidium bromide staining. PCR-assisted mRNA amplification was repeated at least twice for at least two separately prepared cDNA samples for each experiment. Data are representative of at least three different experiments.
Statistical analysis
Survival and organ clearance data from each group of wildtype mice were compared with those from TNF/LT-α-deficient mice using the Mann-Whitney U-test; significance was defined as P Ͻ 0.05. Student's t-test was used to determine statistical significance between cytokine production by the two groups. In vivo groups consisted of four to six animals. The data reported are pooled from three experiments.
Results
TNF/LT-α -/-are more susceptible than TNF/LT-α ϩ/ϩ mice to C. albicans infection
To evaluate the susceptibility of TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice to C. albicans infections, mice were injected i.v. with the highly virulent CA-6, or the live vaccine strain PCA-2, or i.g. with CA-6. Mice were monitored for mortality, fungal load in the organs and resistance to a subsequent lethal challenge. TNF/LT-α -/-mice were more susceptible than wild-type mice to systemic infection with virulent Candida cells, as evidenced by decreased survival observed at the different doses of CA-6. These mice also failed to survive infection with PCA-2, as opposed to wild-type mice that resisted both primary PCA-2 infection and reinfection with CA-6. Moreover, the majority of TNF/LT-α -/-mice succumbed to i.g. infection with the fungus, as opposed to the long-term survival of wild-type mice ( Table 1) . Quantification of yeast cells recovered from infected mice revealed the presence of a higher number of C. albicans cells in the kidneys and brain of systemically infected mice (Fig. 1A) , and in the esophagus and stomachs of i.g. infected TNF/LT-α -/-mice (Fig. 1B) . Interestingly, systemically infected mice also showed a remarkable fungal growth in the liver (data not shown), a finding that is rarely observed in the course of disseminated candidiasis in mice. The results also showed that survival increases and the fungal burden decreases in PCA-2-infected TNF/LT-α -/-mice after a short course of treatment with 3 µg of rTNF-α (Table 1 and Fig. 1 ).
Histological examination of the kidneys from TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice infected i.v. with PCA-2 cells revealed patterns of lesions similar to those observed in mice susceptible or resistant to infection, respectively (43, 44) . Numerous foci of inflammatory reaction (consisting of a few lymphomononuclear cells surrounding hyphal aggregates and yeast cells) were found in the cortex of TNF/LT-α -/-mice, associated with remarkable parenchymal distruction. In contrast, only a few cortical foci of inflammation were present in wild-type mice, with no signs of parenchymal distruction (data not shown). In the gastrointestinal infection, stomach sections from TNF/LT-α -/-mice ( Fig. 2A) revealed the presence of numerous intra-epithelial abscesses consisting of a thickened keratinized outer layer that enveloped a dense aggregate of hyphae and a few infiltrating neutrophils. Large numbers of mononuclear cells were also detected in histologic sections of the submucosal region of the stomach (through the thickness of the mucosa), with conspicuous signs of acanthosis and hypercheratosis. Importantly, abscesses and mucosal infiltration were also observed in regions other than the cardiac-atrial fold, which is a major site of colonization by C. albicans in the gastrointestinal tract (46) . In wild-type mice (Fig. 2C) , only a few yeast cells were present in the keratinized layer, with a limited inflammatory reaction at the mucosal level, mainly observed at the level of the cardiac-atrial fold. Interestingly, numerous abscesses containing hyphal and infiltrating cells were also observed in the esophagus of TNF/LT-α -/-mice (Fig. 2B) , with extensive mononuclear cell responses in the submucosal region, and signs of acanthosis and hyperkeratosis. No similar histopathological lesions were present in the esophagus of wild-type mice (Fig. 2D) . Because the esophagus is not a major site of C. albicans infection and colonization in mice (46) , and the presence of candidiasis in this region is believed to reflect a state of profound host immunosuppression (55), these results indicate that TNF/ LT-α deficiency is associated in mice with an increased susceptibility and pathology to C. albicans infection.
Susceptibility of TNF/LT-α -/-mice to candidiasis is associated with a predominant T h 2 response
As protective and non-protective immunity to C. albicans is associated with preferential expansion of T h 1 and T h 2 cells in mice respectively (29) (30) (31) , parameters of specific T h immunity were examined in TNF/LT-α -/-and wild-type mice upon systemic or gastrointestinal candidiasis. To this purpose, specific IgE and IgG2a levels and production of T h 1 (IFN-γ) and T h 2 (IL-4) cytokines were evaluated in mice injected i.v. with PCA-2 or i.g. with CA-6. In the gastrointestinal infection, local production of IL-6 was also evaluated. At 6 days after infection, serum levels of Candida-specific IgE were higher in TNF/LT-α -/--than in TNF/LT-α ϩ/ϩ -infected mice, as opposed to the serum levels of antigen-specific IgG2a that were higher in infected wild-type than mutant mice (Fig. 3A) . Treatment of mice with systemic candidiasis with exogenous TNF-α reduced IgE production and increased that of IgG2a, the levels of circulating antibodies being comparable to those observed in wild-type mice (data not shown). Upon antigenspecific re-stimulation in vitro, CD4 ϩ T lymphocytes from spleens of TNF/LT-α -/-mice with systemic candidiasis produced less IFN-γ and more IL-4 than CD4 ϩ cells from wildtype mice (Fig. 3B) . A similar pattern of cytokine production was observed in culture supernatants of IGL from orally infected mice (Fig. 3B) . In gastrointestinal infection, a signi- ficant reduction of fecal content of both IFN-γ and IL-6 ( Fig. 3C ) and IgA (data not shown) was also observed in TNF/ LT-α -/-mice as compared to wild-type mice (Fig. 3C) , a finding that confirms the requirement of both cytokines for the development of optimal antifungal response at the mucosal level (48 and unpublished data). Interestingly, serum levels of bioactive IL-12 were comparable in both types of mice, infected either i.v. or i.g. (data not shown). To evaluate the simultaneous gene expression of T h 1 and T h 2 cytokines in TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice upon i.v. infection with 10 6 PCA-2 cells, the levels of IFN-γ, IL-4, IL-10, IL-12Rβ1 and IL-12Rβ2 specific messages were assessed by RT-PCR analysis in CD4 ϩ T cells from spleens at 6 days after infection. In line with previous findings (45) and with the qualitative nature of the results, we found that (Fig. 4A ) the IFN-γ and IL-10 messages were similarly expressed in either type of infected mice; however, the IL-4 message appeared in CD4 ϩ T cells from TNF/LT-α -/-but not from TNF/LT-α ϩ/ϩ mice. It has recently been demonstrated that loss of IL-12 responsiveness, due to a selective loss of IL-12Rβ2 subunit expression, represents an early step in the commitment of T cells to the T h 2 pathway (56,57). Here we show that the IL-12Rβ2 subunit gene expression was transiently induced in highly susceptible TNF/LT-α -/-mice, disappearing 5 days after infection, at a time when it was present in TNF/LT-α ϩ/ϩ mice. The expression of the IL-12Rβ1 subunit was similarly induced and expressed in either type of mice upon C. albicans infection (Fig. 4B) . All together, these results indicate that susceptibility of TNF/LT-α -/-mice to candidiasis is associated with impaired development of T h 1 responses associated with the appearance of CD4 ϩ T h 2 cells producing IL-4.
Antifungal effector functions of neutrophils are impaired in infected TNF/LT-α-deficient mice
As the extent of the fungal load critically affects the developing T h repertoire in mice with candidiasis (58), the ability of effector cells of the innate immune system to control fungal growth through different microbiocidal mechanisms was evaluated in TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice infected with PCA-2. At 3 days after infection, splenic adherent macrophages and peritoneal neutrophils were assessed for ability to phagocytose and kill Candida cells in vitro, and to release NO upon stimulation with IFN-γ and LPS (Fig. 5) . No differences were observed in the ability of macrophages and neutrophils from both types of uninfected mice to phagocytose and kill yeast cells in vitro. Upon infection, these activities were increased in macrophages from both types of mice and in neutrophils from wild-type mice; however, they were significantly impaired in neutrophils from TNF/LT-α -/-mice and partially restored upon treatment with exogenous TNF-α. Release of NO was significantly impaired in both macrophages and neutrophils from either uninfected or infected TNF/LT-α-deficient mice, a finding confirming the co-stimulatory role of TNF in NO production by phagocytes (20) .
In murine candidiasis, IL-12 is both required and prognostic for T h 1 development (45,59), and we have recently found that neutrophils, and to a lesser extent macrophages, are important sources of this cytokine in infected mice (32, 33) . Figure 5 shows that the ability to release IL-12 p70 was not different in neutrophils and macrophages from both types of uninfected mice. Upon infection, neutrophils from both types of mice continued to produce comparable levels of IL-12, whereas macrophage production was undetectable, as expected (33) . Overall, these results indicate that TNF-α is required for the occurrence of optimal innate antifungal responses.
Expression of co-stimulatory molecules is defective in the spleens of TNF/LT-α-deficient mice
To understand the mechanisms underlying the failure of TNF/ LT-α-deficient mice to induce activation of antifungal CD4 ϩ T h 1 cells in the face of an unaltered production of IL-12, the expression of co-stimulatory molecules in vivo, in C. albicansinfected mice, either untreated or treated with recombinant TNF-α was examined. At 3 days after i.v. PCA-2 challenge, macrophages and lymphocytes were purified from spleens and assessed for expression of MHC class I and class II antigens and co-stimulatory molecules by cytofluorometric analysis. No major differences were observed in the expression of MHC class I molecules in both types of mice, either uninfected or after infection ( Table 2 ). The expression of class II MHC antigens and of B7-1 and of B7-2 co-stimulatory molecules on macrophages appeared to be slightly upregulated in uninfected TNF/LT-α -/-as compared to wild-type mice. Upon infection, the number of B7-1-or B7-2-positive cells did not increase in TNF/LT-α -/-mice; however, treatment with rTNF-α increased expression of B7-2. The number of CD40 ϩ cells was reduced in TNF/LT-α-deficient mice and was not modified by infection. However, the percentage of positive cells significantly increased in mice treated with rTNF-α and this was associated with an increased expression of CD40L on T lymphocytes (Table 2) . To determine whether the pattern of expression of co-stimulatory molecules could be associated with defective T lymphocyte activation, IL-2 production was comparatively assessed in mitogen-stimulated cultures of T cells and macrophages from TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice. The results showed ( Table 3 ) that production of IL-2 was greatly reduced in cell cultures from TNF/LT-α -/-mice, as compared to cultures from wild-type mice. The ability to produce IL-2 was partially restored when T lymphocytes from TNF/LT-α -/-mice were stimulated with mitogen in the presence of accessory macrophages from wild-type mice. However, accessory macrophages from TNF/LT-α -/-mice were not as efficient as wild-type macrophages in supporting IL-2 production by T cells from wild-type mice. All together, these results suggest that impaired T lymphocyte activation takes place in the spleens of TNF/LT-α -/-mice, possibly as a result of both T lymphocyte and accessory macrophage defective co-stimulatory function.
Discussion
In this study we have shown that TNF/LT-α deficiencies render mice highly susceptible to both systemic and mucosal C. albicans infections, and incapable of mounting protective T h 1 cell-mediated immunity to the fungus. The interplay between the innate and acquired immune system is considered to be fundamental in the general defense against infections (60) . TNF-α, through endocrine, paracrine or autocrine pathways of activation, appears to be essential for the successful development of both forms of immunity (1) . Systemic infection with the fungus was associated with peripheral neutrophilia, but neither the absolute number of peripheral neutrophils nor the early influx of neutrophils in the spleens were significantly different in TNF/LT-α-deficient and wild-type mice upon infection (data not shown). Thus, the ability of neutrophils to migrate to infection sites does not seem to be affected by TNF/LT-α deficiencies. In contrast, we found that the ability of neutrophils to phagocytose, kill and release NO upon exposure to Candida cells in vitro was severely depressed in TNF/LT-α -/-infected mice, and was partly restored upon treatment with rTNF-α. Although TNF may act as an autocrine and paracrine signal controlling the macrophage secretory response to C. albicans (61) , no defective antifungal ability was exhibited by macrophages from TNF/LT-α-deficient mice, except for NO production. This finding is in line with the general view that the release of TNF-α by macrophages during the early phase of the inflammatory response to the fungus attracts and activates neutrophils for antifungal effector functions (41) . We have recently shown that neutrophils, through production of directive cytokines, such as IL-10 and IL-12, may directly participate in the subsequent development of T h immune responses to C. albicans (31) (32) (33) . In the present study, we found that neutrophils from TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice produced comparable levels of bioactive IL-12 upon in vitro co-stimulation with IFN-γ and LPS. This finding indicates not only that secretion of IL-12 by neutrophils occurs independently of TNF signaling, but also that the impaired development of protective antifungal T h 1 responses in TNF/LT-α-deficient mice occurs in the face of IL-12 production.
One likely mechanism by which activation of non-protective T h 2 cells may occur in susceptible mice is through the increased fungal burden in the organs, as we have shown that production of IL-4, and hence T h 2 cell activation, is strictly dependent on the fungal dose (58) . Both IL-4 neutralization in vivo (43, 58) and reduction of fungal growth by antifungal chemotherapy (62) could redirect the anticandidal T h cell response to the T h 1 pathway. Therefore, the defective antifungal effector functions of neutrophils, and in part of macrophages, and consequently the unopposed fungal growth, may account for the failure of TNF/LT-α-deficient mice to mount a protective T h 1 immune response. However, TNF/LT-α-deficient mice were found to have a disturbed splenic architecture characterized by the absence of distinct B and T cell areas, and absent or reduced expression of adhesion molecules, such as MAdCAM-1, ICAM-1 and VCAM-1 in the marginal zone (26) . Marginal zone macrophages play important roles in trapping foreign substances and in presenting antigens (63) . Interestingly, splenic marginal zone macrophages specifically bind and entrap i.v. injected C. albicans (64) , such that the depletion of marginal zone macrophages greatly increases susceptibility to infection (65) . Since TNF-α regulates the expression of the CD40 molecule Splenic adherent macrophages and elicited peritoneal neutrophils were assessed for ability to phagocytose and kill yeast cells, and to secrete NO and IL-12 p70 in vitro. Assays were done as described in Methods. q, Neutrophils from TNF/LT-α -/-mice given rTNF-α, as described in Methods. A 'Ͻ' indicates below the detection limit of the assay. * P Ͻ 0.05 (infected versus uninfected mice). ** P Ͻ 0.05 (mutant versus wild-type mice). Table 2 . Expression of co-stimulatory molecules in macrophages and lymphocytes from spleens of TNF/LT-α -/-and TNF/LT-α ϩ/ϩ mice infected with C. albicans a Cells were purified from spleens of mice at 3 days after infection with 10 6 PCA-2 cells and stained with the indicated mAb as described in Methods. Naive, uninfected mice.
b rTNF-α (3 µg) was given s.c. twice the day of and once the day after infection. (66) and TNF/LT-α-deficient mice have a reduced expression of this molecule (67), we assessed the expression of the CD40 molecule together with that of B7-1 and B7-2 on splenic macrophages from TNF/LT-α-deficient mice, either uninfected or after C. albicans infection. We found that the expression of CD40 was reduced in TNF/LT-α-deficient mice as compared to wild-type mice, whereas that of B7-2, and to a lesser extent B7-1, was slightly increased. Upon infection, the expression of 
a Splenic T cells were incubated (5ϫ10 6 /ml) with 5ϫ10 5 /ml plasticadherent macrophages in the presence of Con A (10 µg/ml) for 48 h.
b IL-2 levels (U/ml) in culture supernatants, as revealed by cytokinespecific ELISA assay. IL-2 levels in cultures of unstimulated cells were below the detection limit of the assay (Ͻ0.7 U/ml). these co-stimulatory molecules decreased or was unaffected, unless mice were provided with exogenous TNF-α. TNF treatment also resulted in a concomitant increase of CD40L on T lymphocytes. Criss-cross experiments in vitro with splenic macrophages and T cells from either type of mice revealed that the defective T cell activation observed in mutant mice is the consequence of an impaired immune reactivity occurring at the levels of both macrophages and T lymphocytes. Because the macrophage expression of MHC class I or II molecules was not defective, these data would suggest that the impaired T h 1 cell activation that takes place in the spleen of TNF/LT-α-deficient mice, in spite of the presence of IL-12, could be the consequence of a defective co-stimulatory signal to the T cells. That IL-12 synergizes with co-stimulatory molecules in inducing T cell activation and cytokine production has already been demonstrated (68) (69) (70) .
Antigen-specific T cell activation requires the engagement of the T cell receptor with antigen as well as appropriate co-stimulatory molecules (71) . The triggering of the CD28 receptor on T cells by natural ligands, B7-1 and B7-2, provides an effective co-stimulus for T cell activation and cytokine production (72) . B7 provides a co-stimulatory signal for T h 1 and T h 2 cell responses in vivo (73) , although the exact role of B7-1 and B7-2 in the T h 1/T h 2 developmental pathways is not unequivocally defined (74) . In murine candidiasis, blockade of CD28 triggering in vivo results in an impaired production of IL-2 (52) and Candida-induced proliferation of human memory T cells is highly dependent on B7-2 expression on monocytes (75) . The findings of the present study seem to suggest that signaling through the CD40/CD40L pathway is required for T h 1 development in mice with candidiasis. Preliminary experiments indicate that the expression of B7-1, B7-2 and CD40 molecules is differentially regulated in splenic macrophages upon exposure to Candida cells in vitro (unpublished observation). However, the definition of the role of these co-stimulatory molecules in the activation of anticandidal T h responses in vivo, as well as the effect of TNF on the expression of these molecules on different accessory cells, await further clarification.
Whatever the mechanisms by which anticandidal T h cell responses are induced in TNF/LT-α-deficient mice, the results of the present study indicate that a T h 2-type response occurs, as indicated by the high production of IL-4 and extinction of IL-12 signaling, resulting from the selective loss of IL-12Rβ2 expression. Also, the pattern of circulating Candida-specific antibody isotype (high IgE and low IgG2a) correlates with that of mice highly susceptible to the infection. Given the multiple immune abnormalities, including those affecting the levels of antibodies and the mechanisms of antibody isotype switching observed in TNF/LT-α-deficient mice (25) , it is possible that a defective humoral response may also contribute to the high susceptibility of mice to C. albicans infection.
However, to what extent and the mechanisms by which antibodies of different isotypes mediate protective or nonprotective effects in mice with candidiasis is not yet fully understood (76) . In mucosal candidiasis, susceptibility to infection is associated with lack of Peyer's patches, as expected (25) , and with a reduced production of IFN-γ and IL-6, both of which are required for optimal antifungal defense at the mucosal level (48 and unpublished data). Whether the beneficial effect of TNF-α in mice with candidiasis also relies on the downstream production of IL-6 remains to be verified, although preliminary data seem to suggest that TNF-α treatment restores IL-6 production in neutrophils from mutant mice (data not shown). IL-6-deficient mice, although highly susceptible to C. albicans infections, are still resistant to infection with low-virulence C. albicans cells (48) , albeit incapable of mounting protective T h 1 antifungal immunity. Therefore, it appears that an efficient innate antifungal response is operative in IL-6-deficient but not TNF/LT-α-deficient mice.
The results reported here, while confirming the importance of signaling through the TNF receptor p55 in anticandidal defense (15) , establish TNF-α as another cytokine that, via multiple effects on innate response mechanisms, permits development of protective immune T h 1 reactivity.
